Abstract:Replication fork reversal which restrains DNA replication progression is an important protective mechanism in response to replication stress. PARP1 is recruited to stalled forks to restrain DNA replication. However, PARP1 has no helicase activity, and the mechanism through which PARP1 participates in DNA replication restraint remains unclear. Here, we found novel protein-protein interactions between PARP1 and DNA translocases, including HLTF, SHPRH, ZRANB3, and SMARCAL1, with HLTF showing the strongest interaction among these DNA translocases. Although HLTF and SHPRH share structural and functional similarity, it remains unclear whether SHPRH contains DNA translocase activity. We further identified the ability of SHPRH to restrain DNA replication upon replication stress, indicating that SHPRH itself could be a DNA translocase or a helper to facilitate DNA translocation. Although hydroxyurea (HU) and MMS induce different types of replication stress, they both induce common DNA replication restraint mechanisms independent of intra-S phase activation. Our results suggest that the PARP1 facilitates DNA translocase recruitment to damaged forks, preventing fork collapse and facilitating DNA repair. Replication stress induces genomic instability and is associated with cancer development. PARP1 is not only involved in base-excision repair (BER), but also restrains replication fork progression upon replication stress. However, PARP1 has no helicase activities, and the mechanism through which PARP1 participates in the formation of reversed replication forks remains unclear. In the present study, we identified novel protein-protein interactions between PARP1 and DNA translocases, including HLTF, SHPRH, ZRANB3, and SMARCAL1, with HLTF showing the strongest interaction among these DNA translocases. This finding is particularly important because PARP1 inhibitors are effective against homologous recombination deficient cancers. Our study reveals an additional function of PARP1, which restrains replication progression through interaction with DNA translocases and provides an important protective mechanism in response to replication stress.

PARP1 is Required for Chromosomal Translocations.

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

MYELOID NEOPLASIA PARP 1 is required for chromosomal translocations

XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

Transcriptional Roles of PARP1 in Cancer

PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention

PARP Mediated DNA Damage Response, Genomic Stability and Immune Responses

PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair

Molecular Pathways: Targeting PARP in Cancer Treatment

The role of PARP1 in the DNA damage response and its application in tumor therapy

Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis

PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways

The dynamics and Regulation of PARP1 and PARP2 in response to DNA damage and during replication

PARP1 associates with R-loops to promote their resolution and genome stability

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs

Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer

PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis

PARP5B is required for nonhomologous end joining during tumorigenesis in vivo

C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption